PQA 07 - Genitourinary Cancer, Patient Safety, Nursing/Supportive Care

Presentations

• 12:45pm - 02:00pm PT

  4-Year PSA Response and Long-Term Cancer Outcomes in Men Treated with Definitive External Beam Radiotherapy (EBRT) and High Dose Rate Brachytherapy Boost (HDRBT)

  Speaker: Therese Kang, MBBS - Alfred Health, Melbourne
• 12:45pm - 02:00pm PT

  A Dosimetric Study on SBRT Dose De-Escalation in Prostate Cancer Patients

  Speaker: Taran Singh, BS - New York Institute of Technology College of Osteopathic Medicine, Old Westbury
• 12:45pm - 02:00pm PT

  A Quality Control Framework for AI-Based Contouring in Radiotherapy: Clinical Implementation and Validation

  Speaker: Te Zhang, MD - Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an
• 12:45pm - 02:00pm PT

  A Radiation Oncologist's Guide to Quality Improvement in Secondary MRI Data Sets for Treatment Planning Based on FMEA Results

  Speaker: Brad Lofton, MS - Colorado Associates in Medical Physics, Colorado Springs
• 12:45pm - 02:00pm PT

  A Simple Two-Feature Model may Outperform Conventional Risk Classifiers for Metastasis in Prostate Cancer

  Speaker: Elena Borghetti, BS - Huntsman Cancer Institute at the University of Utah, Salt Lake City
• 12:45pm - 02:00pm PT

  A Study on the Safety and Efficacy of Hyperbaric Oxygen Therapy as a First-Line Treatment for Chronic Urinary System Injury in Post-Radiotherapy Prostate Cancer Patients

  Speaker: Xin Qi, MD, MS - Peking University First Hospital, Beijing
• 12:45pm - 02:00pm PT

  A Systematic Approach to Improving Patient Compliance and Experience for Breath-Hold Radiotherapy in Breast Cancer

  Speaker: Ming-Fen Lee, MS - Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi
• 12:45pm - 02:00pm PT

  Acute Toxicity and Patient Reported Urinary Quality of Life of Prostate Radiotherapy Following Holmium Laser Enucleation (HoLEP)

  Speaker: Trevor Wilson, MD, BS - UW Health Radiation Oncology, Madison
• 12:45pm - 02:00pm PT

  Acute Toxicity of SBRT in Localized Prostate Cancer: A Multicenter Spanish Study

  Speaker: Sigfredo Elias Romero Zoghbi, MD - Departament of Radiation Oncology, GenesisCare, Talavera de la Reina
• 12:45pm - 02:00pm PT

  Adjuvant IMRT in Locally Advanced Penile Cancer: Clinical Performance of an Institutional Inguinal Contouring Guideline

  Speaker: Priyamvada Maitre, MD, MBBS - Tata Memorial Centre, Manchester
• 12:45pm - 02:00pm PT

  An Intermittently Inflated Large-Volume Balloon Spacer for Protecting Rectum during Prostate Cancer Radiotherapy: Initial Animal Study

  Speaker: Xin Qi, MD, MS - Peking University First Hospital, Beijing
• 12:45pm - 02:00pm PT

  Assessing the Predictive Accuracy of Radiogenomic Models Incorporating the Decipher Genomic Classifier and Radiomic Features for Biochemical Recurrence in Prostate Cancer

  Speaker: Oluwaseyi Oderinde, PhD - Purdue University, West Lafayette
• 12:45pm - 02:00pm PT

  Assessment of Non-Randomized Comparisons of Radical Prostatectomy vs. Radiation Therapy for Prostate Cancer

  Speaker: Zakaria El Kouzi, MD - MD Anderson Cancer Center, Houston
• 12:45pm - 02:00pm PT

  Association between Intraoperative Dosimetric Parameters and Urinary Acute and Late Toxicity after Low-Dose-Rate Brachytherapy

  Speaker: Estelle Vigneau, MD - Institute Jean Godinot, Reims
• 12:45pm - 02:00pm PT

  Associations between Obesity and Survival in Metastatic Renal Cell Cancer Patients Receiving Immunotherapy

  Speaker: Daniel Yang, MD - University of Texas Southwestern Medical Center, Dalals
• 12:45pm - 02:00pm PT

  Automated Mapping of Bladder Subregions to Assess Localized Dose-Response Patterns in Trimodality Therapy for Muscle Invasive Bladder Cancer

  Speaker: Matthew Whitmill, MD - UNC Health, Chapel Hill
• 12:45pm - 02:00pm PT

  Automated Quality Assurance for Diagnosis of Common Contouring Errors in Radiotherapy Structure

  Speaker: Shaobin Wang, PhD - Tsinghua Unversity, Beijing
• 12:45pm - 02:00pm PT

  Breaking Barriers in Lung Cancer Screening: Understanding Provider-Level Challenges

  Speaker: Akul Munjal, MD - UC Irvine Health, Orange
• 12:45pm - 02:00pm PT

  Cardiovascular Disease and Diagnosis of Advanced Prostate Cancer

  Speaker: Kevin Nead, MD, MPhil - The University of Texas MD Anderson Cancer Center, Houston
• 12:45pm - 02:00pm PT

  Changes in Prostate Volume during Prostate SBRT Delivered on an MR-Linac and Correlation with Acute Toxicity

  Speaker: Jason Gurewitz, DO - NYU Langone Health, New York
• 12:45pm - 02:00pm PT

  Changing Landscapes of Adjuvant Radiotherapy after Prostatectomy in Prostate Cancer

  Speaker: Harshath Gupta, MD - MD Anderson Cancer Center, Houston
• 12:45pm - 02:00pm PT

  Characteristics and Prognostic Implications of PSA Bounce in Prostate Cancer Patients Treated with Stereotactic Body Radiotherapy (SBRT)

  Speaker: Andrea Romei, MD - Radiation Oncology, Careggi University Hospital, University of Florence, Florence
• 12:45pm - 02:00pm PT

  Clinical Correlation of Physician and Auto-Generated Contours on Post-Implant CT Following Low Dose Rate Brachytherapy

  Speaker: Anirudh Bommireddy, MD - Cleveland Clinic Foundation, Cleveland
• 12:45pm - 02:00pm PT

  Clinical Efficacy of Salvage Re-Irradiation for Recurrent Localized Prostate Cancer Using CBCT- and Surface Mapping-Guided Proton Scanning Beams: A Single Institute Study with 32.5-Month Follow-Ups

  Speaker: Charles Shang, MB, MS - South Florida Proton Therapy Institute, Delray Beach
• 12:45pm - 02:00pm PT

  Clinical Feasibility and Safety of 1.5 T MR-Guided Daily Adapted Radiotherapy in 1000 Patients: A Real-World Large Experience of an Early-Adopter Center

  Speaker: Filippo Alongi, MD, PhD, RT, PROF - University of Brescia and IRCCS Negrar, Negrar di Valpolicella
• 12:45pm - 02:00pm PT

  Clinical Outcomes for Extracranial Oligometastatic Renal Cell Carcinoma Treated with Stereotactic Body Radiotherapy - Institutional Experience

  Speaker: Justyn Nakashima, DO - Moffitt Cancer Center, Tampa
• 12:45pm - 02:00pm PT

  Clinical Outcomes of Patients with Histologic Subtypes of Bladder Cancer Treated with Trimodality Therapy

  Speaker: Anirudh Bommireddy, MD - Cleveland Clinic Foundation, Cleveland
• 12:45pm - 02:00pm PT

  Clinical Outcomes of Salvage Nodal Radiotherapy for Prostate Cancer with Prior Radiotherapy

  Speaker: Maheen Ansari, BS - MD Anderson Cancer Center, Houston
• 12:45pm - 02:00pm PT

  Collaborative Development of a Universal Applicator Clamping Device for Brachytherapy through 3D Printing

  Speaker: Daniel Hernandez Martinez, MD - Centro Universitario Contra el Cancel UANL, Monterrey
• 12:45pm - 02:00pm PT

  Combination of Axitinib, Toripalimab, and Radical-Dose Radiotherapy for Recurrent or Metastatic Renal Cell Carcinoma: A Single-Center Prospective Study

  Speaker: Mingwei Ma, MD - Peking University First Hospital, Beijing
• 12:45pm - 02:00pm PT

  Combining Risk Matrix and Network Theory to Improve Risk Analysis in Radiotherapy

  Speaker: Manuel Arevalo, - Universidad Nacional de Colombia, Bogota
• 12:45pm - 02:00pm PT

  Comparative Analysis of Lymph Node-Only vs. Bone-Only Metastasis-Directed Radiation Therapy in Oligorecurrent Prostate Cancer

  Speaker: Vivek Aslot, BS - The University of Toledo College of Medicine, Toledo
• 12:45pm - 02:00pm PT

  Comparing PSMA PET/CT and MRI in Prostate Radiotherapy Planning: Which Modality Better Predicts Seminal Vesicle Involvement?

  Speaker: Jasmesh Sandhu, MB, ChB - NHS, London
• 12:45pm - 02:00pm PT

  Comparing Urethral Delineation Methods in Prostate SBRT: Impact on Acute GU Toxicity

  Speaker: Tejinder Kataria, MD, DNB, CCST - Medanta-The Medicity, Gurgaon
• 12:45pm - 02:00pm PT

  Comparison of Adaptive Magnetic Resonance Guided and Computed Tomography Guided Stereotactic Body Radiation Therapy for Prostate Cancer

  Speaker: Yoonsun Jee, MD - Henry Ford Hospital-Henry Ford Cancer Institute, Detroit
• 12:45pm - 02:00pm PT

  Comparison of Circulating Tumor DNA and PSA after Prostate Cancer Treatment: A Retrospective Analysis

  Speaker: Eleen Garemanian, Student - UC Irvine Health, Orange
• 12:45pm - 02:00pm PT

  Comparison of Patients with Early Salvage Radiotherapy and Low PSA Levels (Pre-SRT-PSA = 0.3 ng/ml) - A Retrospective Analysis of Patients with Persisting or Increasing PSA after Radical Prostatectomy for Prostate Cancer

  Speaker: Thomas Wiegel, MD - University Hospital Ulm, Ulm
• 12:45pm - 02:00pm PT

  Comparison of Survival and Adverse Events in Localized High-Risk Prostate Cancer Treated with IMRT+ADT vs. Trimodality Therapy (LDR-Brachytherapy + EBRT+ADT)

  Speaker: Yutaka Kitagawa, MD, PhD - Tottori University, Yonago
• 12:45pm - 02:00pm PT

  Conception to Development of a First-of-Its-Kind Ultra Compact, Affordable and Ergonomic Scalp Cooling System for Preventing Chemotherapy-Induced Alopecia

  Speaker: Kathryn Tsai, BS - Carle Illinois College of Medicine, Urbana
• 12:45pm - 02:00pm PT

  CONSOLIDATE: Concurrent Radiotherapy with Enfortumab vedotin (EV) for Locally Advanced Bladder Cancer

  Speaker: Patrick Carriere, MD, PhD - MD Anderson Cancer Center, Houston
• 12:45pm - 02:00pm PT

  Convolutional Neural Network (CNN)-Based Segmentation Method for Automatic Clinical Target Volume (CTV) Contouring in Strut-Based Applicator Brachytherapy in Breast Cancer

  Speaker: Minh Nguyen, MS, BS - East Carolina University Brody School of Medicine, Greenville
• 12:45pm - 02:00pm PT

  Could PSMA PET/CT post Definitive Radiation Therapy (RT) and Androgen Deprivation Therapy (ADT) Detect Viable Residual Tumor with a Non-Rising PSA?

  Speaker: Alina Goltser, MD - Sheba Medical Center, Ramat Gan
• 12:45pm - 02:00pm PT

  CT-Guided Adaptive SBRT with Simultaneous Integrated Boost for Prostate and Pelvic Nodes in High-Risk and Unfavorable Intermediate-Risk Prostate Cancer: Interim Analysis

  Speaker: Weiren Liu, MD, MS - Washington University School of Medicine in St. Louis, St. Louis
• 12:45pm - 02:00pm PT

  Current Evidence for the Use of Reflectance Confocal Microscopy in Assessing Radiation Dermatitis

  Speaker: Hamail Iqbal, BS - Cooper Medical School of Rowan University, Camden
• 12:45pm - 02:00pm PT

  Frameless Robotic Radiosurgery System Stereotactic Body Radiation Therapy (SBRT) Dose Escalation Prostate Cancer Trial (CK-DESPOT) for Unfavorable Intermediate and High-Risk Prostate Cancer

  Speaker: Mark Nguyen, MD, BA - University of Washington School of Medicine, Seattle
• 12:45pm - 02:00pm PT

  Daily Adaptive RadioTherapy in Postoperative HypofrActionated Salvage radiothERapy for Prostate Cancer Patients (DART-PHASER): Early Clinical and Dosimetric Results

  Speaker: Filippo Alongi, MD, PhD, RT, PROF - University of Brescia and IRCCS Negrar, Negrar di Valpolicella
• 12:45pm - 02:00pm PT

  Daily CBCT-Based Dose Accumulation Unveils Spatial Dependency of Dominant Intraprostatic Lesion Coverage and Urinary Toxicity in Hypofractionated Prostate Radiotherapy

  Speaker: Yan Gao, MD, MS - Peking University First Hospital, Beijing
• 12:45pm - 02:00pm PT

  Development of a Radioimmunotherapy Score for Identifying SBRT-Treated Renal Cell Carcinoma Patients Eligible for Immunotherapy

  Speaker: Qingyu Huang, MD - Renmin Hospital, Wuhan University, Wuhan
• 12:45pm - 02:00pm PT

  Disparities in Access to Radiotherapy for Prostate Cancer across Brazil: A Cross-Sectional Analysis

  Speaker: Andre Gouveia, MD, MBA - McMaster University, Hamilton
• 12:45pm - 02:00pm PT

  Dose Reconstruction for Helical Delivery Verification Using Optical Sensor Data

  Speaker: Guang-Pei Chen, PhD - Medical College of Wisconsin, Milwaukee
• 12:45pm - 02:00pm PT

  Dose-Escalated Intensity Modulated Proton Therapy (IMPT) for Node-Positive Prostate Cancer - First Report of Clinical Outcomes

  Speaker: Marcio Fagundes, MD - Miami Cancer Institute, Miami
• 12:45pm - 02:00pm PT

  Dosimetric Impact of Online MR-Guided Adaptive Radiotherapy for Focal-Boosted Prostate Stereotactic Body Radiation Therapy

  Speaker: Jonathan Pham, PhD - UCLA, Los Angeles
• 12:45pm - 02:00pm PT

  Early Detection of Prostate Cancer Immune Response to Radiation and Androgen Deprivation Therapy: Unleashing the Power of HRS Mpmri Imaging, Molecular Biomarkers and Digital Pathology

  Speaker: Benjamin Spieler, MD - Department of Radiation Oncology, Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami
• 12:45pm - 02:00pm PT

  Early Outcomes from a Prospective Phase II Trial of Pencil Beam Scanning Proton SBRT for Prostate Cancer

  Speaker: Daniel Gorovets, MD - Memorial Sloan Kettering Cancer Center, New York
• 12:45pm - 02:00pm PT

  Economic Efficiency in Radiotherapy: An Innovative Approach to Customized Bolus

  Speaker: Ana Carolina Ahumada Pamanes, MD - Centro Universitario Contra el Cancer UANL, Monterrey
• 12:45pm - 02:00pm PT

  Efficacy and Toxicity of PSMA-PET Guided Radiation Therapy to Newly Diagnosed Node Positive Prostate Cancer with Mesorectal Node Involvement

  Speaker: Haripriya Vettivelu, BMed - Mid North Coast Cancer Institute (MNCCI) Coffs Harbour, Coffs Harbour
• 12:45pm - 02:00pm PT

  Enhancing Precision in Bladder Cancer Adaptive Radiotherapy: The Benefit of Plan of the Day Treatment for Improved Target Coverage and Reducing Toxicity

  Speaker: Sadia Sadiq, MBBS, FCPS - Inmol Hospital(Lahore)Punjab, Lahore
• 12:45pm - 02:00pm PT

  Enhancing Quality and Efficacy in HDR Brachytherapy for Gynecological Cancers: A Multidisciplinary Approach by Using an Auto-Alert Information System and Innovative Solutions

  Speaker: Ming-Fen Lee, MS - Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi
• 12:45pm - 02:00pm PT

  Enhancing TG-263 Target Naming Accuracy: A WPF Application for Resident Training

  Speaker: Andrew Simpson, MD - UAB Radiation Oncology, Birmingham
• 12:45pm - 02:00pm PT

  Estimation of a/ß Ratio for Late Genitourinary Toxicity Following Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer

  Speaker: Seiya Takano, MD, PhD - Nagoya City University Graduate School of Medical Sciences, Nagoya
• 12:45pm - 02:00pm PT

  Evaluating Factors Related to Clinical Failure and Toxicity in Patients with Prostate Cancer Treated By a Low-Dose-Rate Brachytherapy

  Speaker: Yasushi Nakai, MD, PhD - Nara Medical University, Kashihara
• 12:45pm - 02:00pm PT

  Evaluating the Criteria for Cure after Low-Dose-Rate Brachytherapy for Prostate Cancer

  Speaker: Kenta Onishi, MD, PhD - Nara Medical University, Kashihara
• 12:45pm - 02:00pm PT

  Evaluating the Use of ⁶⁸Ga-PSMA for Biology-guided radiotherapy (BgRT) Treatment on PET-Linac Platform

  Speaker: Neil Desai, MD - University of Texas Southwestern Medical Center, Dallas
• 12:45pm - 02:00pm PT

  Evaluation of Intra-Fraction Motion of Prostate during SBRT Using Four-Dimensional Trans Perineal Ultrasound (TPUS) and Analysis of the Data for Calculation of PTV Margins

  Speaker: Amrit Neupane, MBBS - All India Institute of Medical Sciences, New Delhi
• 12:45pm - 02:00pm PT

  Expanding Ultra-Hypofractionated Radiotherapy: A 12-Fraction, 51.6Gy Regimen for Locally Advanced and Node-Positive Prostate Cancer

  Speaker: Alina Goltser, MD - Sheba Medical Center, Ramat Gan
• 12:45pm - 02:00pm PT

  Exploring Supportive Care Needs in Cancer Patients Undergoing Radiotherapy: A Latent Profile Analysis

  Speaker: Yingtao Meng, - Shandong Cancer Hospital and Institute, Shandong First University, Jinan
• 12:45pm - 02:00pm PT

  Factors Influencing Treatment Termination in Head and Neck Cancer: Insights from a 10-Year Analysis

  Speaker: Kunika Chahal, MPH, BEng - SUNY Downstate College of Medicine, New York
• 12:45pm - 02:00pm PT

  Focal Boosted IMRT Treatment of Prostate Cancer to 84 Gy in 28 Fractions: Extended Follow-up

  Speaker: Jacob Hands, - The George Washington University School of Medicine and Health Sciences, Washington DC
• 12:45pm - 02:00pm PT

  From Chaos to Control: Simplifying Physics Equipment Inventory Management

  Speaker: Virginia Lockamy, PhD - University of Pennsylvania, Philadelphia
• 12:45pm - 02:00pm PT

  Genomic Tumor Testing in NCCN Favorable and Unfavorable Intermediate-Risk Prostate Cancer Informs Treatment Intensity: Data from an Open Access Research Registry

  Speaker: Christopher Lee, MD - Cancer Care Northwest, Spokane Valley
• 12:45pm - 02:00pm PT

  Handheld Bladder Scanners Improve Treatment Efficiency and Safety during Radiation Therapy for Prostate Cancer

  Speaker: Bruce McGibbon, MD - Yale University, Greenwich
• 12:45pm - 02:00pm PT

  High Dose Rate Brachytherapy Boost in Intermediate and High Risk Localized Prostate Cancer: A Retrospective Study on Toxicity and Clinical Outcomes

  Speaker: Imtiaz Ahmed, MB, BS, MRCP, FRCR - Southend University Hospital NHS Foundation Trust, Essex SSO ORY
• 12:45pm - 02:00pm PT

  High Dose-per-Fraction Definitive Radiotherapy after Prior Ablative Treatment of Prostate Cancer

  Speaker: Patrick Courtney, MD, MAS - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles
• 12:45pm - 02:00pm PT

  High Rates of Treatment Regret and Recurrence with Focal Radiation Therapy: Long-Term Follow-up of a Pilot Trial for Intermediate-Risk Prostate Cancer

  Speaker: Samuel Lichtman-Mikol, MD - Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland
• 12:45pm - 02:00pm PT

  Hormone Changes Associated with Metformin Treatment in Prostate Cancer Patients Initiating Androgen Deprivation Therapy: A Correlative Analysis of the PRIME Study

  Speaker: Mathew Gorman, MD - Cross Cancer Institute, Edmonton
• 12:45pm - 02:00pm PT

  Identifying Intermediate-Risk Prostate Cancer Patients Appropriate for Active Surveillance Using Recursive Partitioning Analysis and Long-Term Follow-up

  Speaker: Ruben Del Castillo, MD - Sunnybrook Odette Cancer Centre, Toronto
• 12:45pm - 02:00pm PT

  Identifying Sources of Delay to Definitive Chemoradiation for Head and Neck Cancer Patients Evaluated in a Co-Located Multidisciplinary Clinic

  Speaker: Jessica Maaskant, MS, BS - Emory University School of Medicine, Atlanta
• 12:45pm - 02:00pm PT

  Impact of Bladder Filling on External Beam Radiotherapy for Prostate Cancer: A Mixed-Methods Analysis in a Large, Integrated Cancer Network

  Speaker: Diala Hamade, MD - University of Pittsburgh Medical Center, Pittsburgh
• 12:45pm - 02:00pm PT

  Impact of CT Calibration Method on Proton Plan Dosimetry

  Speaker: Li Zhao, PhD - Medical College of Wisconsin, Milwaukee
• 12:45pm - 02:00pm PT

  Impact of Dedicated Head & Neck Cancer (HNC) Subspecialty Peer Review on Contouring Accuracy and Plan Quality in an Integrated Health Network

  Speaker: Jenna Kocsis, MD - Cleveland Clinic Taussig Cancer Center, Cleveland
• 12:45pm - 02:00pm PT

  Impact of Pre-Therapy PSA Kinetics on Overall Survival of Prostate Cancer Patients Treated with Lu-177 PSMA 617

  Speaker: Vikas Prasad, MD, PhD - Washington University School of Medicine in St. Louis, St. Louis
• 12:45pm - 02:00pm PT

  Impact of PSMA PET/CT on Initial Staging and Definitive Radiation Therapy Planning in Prostate Cancer

  Speaker: Omar Awad, MD, MS - Baylor College of Medicine, Houston
• 12:45pm - 02:00pm PT

  Impact of Rectal Spacer Implant Quality on Rectal Dose and Toxicity in Prostate Radiotherapy: Results from a Prospective Clinical Trial

  Speaker: Shawn Zimberg, MD - Advanced Radiation Centers of New York, North Hills
• 12:45pm - 02:00pm PT

  Implementation of an Automated Quality Analytics Dashboard to Reduce Planning Bottlenecks

  Speaker: Nicolas Prionas, MD, PhD - University of California San Francisco, San Francisco
• 12:45pm - 02:00pm PT

  Implementing CT-Guided Online Adaptive Radiation Therapy (CT-ART) without Destroying the Clinic: A First Year Workflow

  Speaker: Zachary Kiss, DO - Fox Chase Cancer Center, Philadelphia
• 12:45pm - 02:00pm PT

  Improving the Workflow and Rate of Scheduled Follow-up Visits within a Radiation Oncology Department

  Speaker: Casey Hollawell, MD - Hospital of the University of Pennsylvania, Philadelphia
• 12:45pm - 02:00pm PT

  In the Eye of the Beholder: Utilizing Lean Process Improvement of Uveal Melanoma Brachytherapy Service Line to Expand Rural Oncology Equity

  Speaker: Enes Atici, MD - University of Kentucky, Lexington
• 12:45pm - 02:00pm PT

  Innovative No-Reference Image Quality Assessment for MRI-Guided Radiotherapy: Automated Distortion Detection

  Speaker: Jiayun Chen, PhD - Cancer Hospital Chinese Academy of Medical Sciences, Beijing
• 12:45pm - 02:00pm PT

  Investigating Effects of Film Digitization Methods on IROC SRS Head Phantom Credentialing Results

  Speaker: Michael Yang, BS - MD Anderson Cancer Center, Houston
• 12:45pm - 02:00pm PT

  Investigation of the Safety of Radium-223 Chloride in Combination with External Beam Radiotherapy for Bone Metastases of Prostate Cancer

  Speaker: Soichi Makino, MD - Shin KUKI General Hospital, Kuki
• 12:45pm - 02:00pm PT

  In-Vivo Time-Resolved Optical Dosimetry with Line Measurement and Source Tracking for Prostate High-Dose-Rate Brachytherapy

  Speaker: Kevin Willy, BS - Dartmouth College, Lebanon
• 12:45pm - 02:00pm PT

  Is Early GU Radiation Toxicity in Prostate Cancer Patients Bladder-Related?

  Speaker: Wojciech Majewski, MD, PhD - Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice
• 12:45pm - 02:00pm PT

  Large Language Models Applied to Patient Messages for Predicting Acute Care Risk during Radiation Therapy

  Speaker: Benjamin Hyams, BA - University of California San Francisco, San Francisco
• 12:45pm - 02:00pm PT

  Late Genitourinary Toxicity in Prostate Cancer Patients with PRIOR Transurethral Resection of the Prostate: A Comparative Analysis of Radiotherapy with vs. without Simultaneous Integrated BOOST

  Speaker: Huseyin Cem Onal, MD - Baskent University Faculty of Medicine, Adana
• 12:45pm - 02:00pm PT

  Late Proctitis Rates Following Moderately-Hypofractionated Image-Guided Prostate Radiotherapy Using Fiducials vs. Cone Beam Computed Tomography

  Speaker: Nancy Zhou, MD - Kaiser Permanente Los Angeles Medical Center, Los Angeles
• 12:45pm - 02:00pm PT

  Long Term Metastasis-Free Survival of a Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS) Study

  Speaker: Yutaka Shiraishi, MD, PhD - Keio University School of Medicine, Shinjuku-ku
• 12:45pm - 02:00pm PT

  Long-Term Bowel, Urinary, and Sexual Dysfunction Following Brachytherapy for Prostate Cancer with or without Rectal Spacer

  Speaker: Michael Folkert, MD, PhD - University of Washington Radiation Oncology, Seattle
• 12:45pm - 02:00pm PT

  Long-Term Outcomes Following Proton Therapy for Prostate Cancer in Men Ages 50 and Younger

  Speaker: Miscia Fortna, BS - Louisiana State University Health Sciences Center, New Orleans
• 12:45pm - 02:00pm PT

  Long-Term Results of Prostate Stereotactic Body Radiation Therapy (SBRT) with Real-Time Tracking and Novel Urethral- and Rectal-Sparing Techniques

  Speaker: Katherine Amarell, MD, BS - Cleveland Clinic Foundation, Cleveland
• 12:45pm - 02:00pm PT

  Luminal Subtypes in Metastatic Prostate Cancer Circulating Tumor Cells Mirror Tissue and Are Associated with Prognosis and Response to 177Lu-PSMA-617

  Speaker: Scot Callahan, MD, PhD - UW Carbone Cancer Center, Madison
• 12:45pm - 02:00pm PT

  Management of a Head and Neck Cancer Patient with a Deep Brain Stimulator Undergoing Radiation Therapy

  Speaker: Nazanin Hoshyar, PhD - Bay Pines VA Medical Center, Bay Pines
• 12:45pm - 02:00pm PT

  Management of Metastatic Castration-Resistant Prostate Cancer (mCRPC) at the Veterans Affairs Healthcare System (VAHCS): A Real-World Assessment of Modern Patterns of Care, Oncologic Outcomes, and Adverse Events (AEs)

  Speaker: Anthony Nguyen, MD, PhD - Cedars-Sinai Medical Center, Los Angeles
• 12:45pm - 02:00pm PT

  Mapping Patterns of Pelvic Lymph Node Metastasis in Bladder Urothelial Carcinoma Stratified by T-Stage and G-Grade: Implications for Personalized Pelvic Radiotherapy

  Speaker: Tian Cheng, MD, MBBS - Peking University First Hospital, Beijing
• 12:45pm - 02:00pm PT

  MRI PI-RADS Lesion Location in Transitional vs. Peripheral Zone and Impact on Acute GU Toxicity Following Prostate SBRT Microboost

  Speaker: Jonathan Lischalk, MD - Georgetown University School of Medicine, Washington
• 12:45pm - 02:00pm PT

  MRI-Defined Prostatic Gross Extracapsular Extension Association with Acute GU and GI Toxicity Following SBRT

  Speaker: Jonathan Lischalk, MD - Georgetown University School of Medicine, Washington
• 12:45pm - 02:00pm PT

  Multi-Institutional Analysis of Extracranial Oligometastatic Bladder Cancer Patients Treated with Stereotactic Body Radiotherapy

  Speaker: Ozan Cem Guler, MD - Baskent University, Adana
• 12:45pm - 02:00pm PT

  Multivariate Survival Analysis Comparing Proton Therapy and IMRT for Localized Prostate Cancer: A Retrospective Observational Study

  Speaker: Phillip Given, BA - Eastern Virginia Medical School, Norfolk
• 12:45pm - 02:00pm PT

  Novel Insights into Urethral Sphincter Complex Dosimetry and GU Toxicity of MR-Guided Stereotactic Body Radiotherapy (MRgSBRT) in Localized Prostate Cancer:Single-Institution Study

  Speaker: Marcus Kaho Siu, RT - HKSH Medical Group Limited, Hong Kong
• 12:45pm - 02:00pm PT

  Online Adaptive Radiotherapy Based Integrated CT-Linac for Limited-Stage Small Cell Lung Cancer: A Prospective Phase II Trial

  Speaker: Baiqiang Dong, MD, PhD - Sun Yat-Sen University Cancer Center, Guang Dong Province
• 12:45pm - 02:00pm PT

  Operational Time Savings with Prospective Peer View

  Speaker: Sarah Quirk, PhD - Dana-Farber/Brigham and Women's Cancer Center, Boston
• 12:45pm - 02:00pm PT

  Optimizing Inter-Facility Patient Transfers for Radiation Therapy in an Integrated Health System

  Speaker: Pranshu Mohindra, MD, MMM - University Hospitals Seidman Cancer Center, Cleveland, OH, Cleveland
• 12:45pm - 02:00pm PT

  Outcomes of Oligorecurrent Prostate Cancer Treated with Metastasis Directed Therapy

  Speaker: Elizabeth Obi, MD - Cleveland Clinic Foundation, Cleveland
• 12:45pm - 02:00pm PT

  Outcomes of Stage IIA and Stage IIB Seminoma Treated with Definitive Radiation Therapy

  Speaker: Ansel Nalin, MD, PhD - MD Anderson Cancer Center, Houston
• 12:45pm - 02:00pm PT

  Outcomes of Stereotactic Body Radiotherapy (SBRT) for Supraclavicular Lymph Node Metastasis (SCLN) among Patients with Metastatic Prostate Cancer

  Speaker: Andres Frias, MD - Mayo Clinic College of Medicine and Science Rochester, Rochester
• 12:45pm - 02:00pm PT

  Outcomes with Salvage Dose-Escalated Intensity Modulated Proton Therapy in Node-Positive Recurrence after Prostatectomy

  Speaker: Adeel Kaiser, MD - Miami Cancer Institute, Miami
• 12:45pm - 02:00pm PT

  Patient Demographic Factors Associated with Radiation Cystitis Development following Radiation for Prostate Cancer

  Speaker: Rachel Moses, MD - Dartmouth Health, Lebanon
• 12:45pm - 02:00pm PT

  Patient Education through Virtual Reality: Project Implementation

  Speaker: Michelle Rokni, MS - Novant Health, Winston-Salem
• 12:45pm - 02:00pm PT

  Patterns and Risk Factors of Locoregional Recurrence after Radical Nephrectomy for Localized Renal Cell Carcinoma: Implications for Patient Selection in Adjuvant Radiotherapy

  Speaker: Ke Hu, MD - Peking University First Hospital, Beijing
• 12:45pm - 02:00pm PT

  Per Lesion Metabolic Change on Serial PSMA PET Imaging for Metastatic Prostate Cancer Patients

  Speaker: Naasik Syed, BS - UTSW, Dallas
• 12:45pm - 02:00pm PT

  Physician Utilization of Low Dose Rate and High Dose Rate Brachytherapy for Prostate Cancer in Medicare Patients over a 10-Year Span (2013-2022)

  Speaker: Kathryn Achuck, MD, BA - Santa Clara Valley Medical Center, San Jose
• 12:45pm - 02:00pm PT

  Placing the Pin Back into the Stone Cushion: A Salvage HDR Brachytherapy Experience

  Speaker: Robert Freeman, MD - Fox Chase Cancer Center, Philadelphia
• 12:45pm - 02:00pm PT

  Postoperative Hypofractionated Radiotherapy for Prostate Cancer: Late Toxicity and Clinical Outcomes

  Speaker: Xueying Ren, MD - Radiation of Oncology, Peking University First Hospital, Beijing
• 12:45pm - 02:00pm PT

  Predicting Response to ¹⁷⁷Lu-PSMA-617 Using Pre-Treatment Clinical Biomarkers

  Speaker: Jackson Howell, MD - University of Utah Huntsman Cancer Institute, Salt Lake City
• 12:45pm - 02:00pm PT

  Predicting the Early Complete Biochemical Response in MRgSBRT in Prostate Cancer with Intraprostatic Lesion Boost

  Speaker: Oilei Wong, PhD - Hong Kong Sanatorium and Hospital, Hong Kong
• 12:45pm - 02:00pm PT

  Predictive Value of Pre- and Post-Treatment Tumor Apparent Diffusion Coefficient in High-Risk Prostate Cancer Patients Undergoing Definitive Radiotherapy: Long-Term Analysis from a Single-Institution Study

  Speaker: Huseyin Cem Onal, MD - Baskent University Faculty of Medicine, Adana
• 12:45pm - 02:00pm PT

  PREDICTO-Ren - Personalized Radiomics-basEd Determination of Individual Cancer Treatment Outcome in Patients with Renal Cancer

  Speaker: Felipe Restini, MD - McGill University Health Center, Montreal
• 12:45pm - 02:00pm PT

  Predictors of PSA Response and Hematologic Changes in Patients Undergoing Lu-177-PSMA-617 Radiopharmaceutical Therapy: A Multivariate Analysis

  Speaker: Edmond Yaghoubian, MD - UPMC, Pittsburgh
• 12:45pm - 02:00pm PT

  Pre-Formed Radiopaque Hydrogel for Perirectal Spacing in Subjects with Low to Intermediate Risk Prostate Cancer Undergoing External Beam Radiotherapy (EBRT): A Multicenter, Randomized, Controlled Clinical Study (HYDROSPACE)

  Speaker: Brian Baumann, MD - Springfield Clinic, Springfield
• 12:45pm - 02:00pm PT

  Preliminary Acute Toxicity Results of Locally Advanced Prostate Cancer Treated with MR-guided Radiotherapy

  Speaker: Ezgi Oymak, MD - VKV Amerikan Hastanesi, Istanbul
• 12:45pm - 02:00pm PT

  Preliminary Outcomes of a Phase II Trial of Focal Salvage LDR Brachytherapy for Local Recurrence of Prostate Cancer following External Beam Radiation Therapy

  Speaker: Ting Martin Ma, MD, PhD - University of Washington, Seattle
• 12:45pm - 02:00pm PT

  Preliminary Results of a Prospective Cohort Study on the Protective Effect of Bone Marrow Protection Against Lymphocytopenia during Radiotherapy in Prostate Cancer

  Speaker: Huan Zhang, MD - Peking University First Hospital, Beijing
• 12:45pm - 02:00pm PT

  Premature Radiation Treatment Terminations in Gynecologic Cancer Patients: Assessment of 10 year Database Using a Novel Score at a Tertiary Care Center

  Speaker: Oluwatimileyin Ojo, MD - Northwell Health, Lake Success
• 12:45pm - 02:00pm PT

  Prognostic Factors for Recurrence and Survival in Bladder-Preserving Therapy for Muscle-Invasive Bladder Cancer

  Speaker: Nicolas Feltes, RT - Consorci Sanitari de Terrassa, Terrassa
• 12:45pm - 02:00pm PT

  Propensity Score Matched Analysis of External Beam Radiotherapy with or without Focal Boost to Intraprostatic Lesions in Prostate Cancer

  Speaker: Huseyin Cem Onal, MD - Baskent University Faculty of Medicine, Adana
• 12:45pm - 02:00pm PT

  ProstACT Global: A Phase 3 Study of Lutetium (Lu177) Rosopatamab Tetraxetanplus Standard of Care vs. Standard of Care Alone in Patients with Metastatic Castration-Resistant Prostate Cancer

  Speaker: Dustin Boothe, MD - Intermountain Healthcare, Salt Lake City
• 12:45pm - 02:00pm PT

  Prostate Auto-Segmentation Model for MRI with or without Hydrogel Spacer

  Speaker: Yuze Song, MS - UC San Diego Radiation Medicine and Applied Sciences, La Jolla
• 12:45pm - 02:00pm PT

  Prostate Reirradiation with Online Daily-Adaptive Stereotactic Body Radiotherapy (SBRT) on 1.5T MR-Linac

  Speaker: Andrea Romei, MD - Radiation Oncology, Careggi University Hospital, University of Florence, Florence
• 12:45pm - 02:00pm PT

  Prostate Volume Reduction in Prostate Cancer: Predictive Factors after LHRHa Therapy

  Speaker: Nicolas Feltes, RT - Consorci Sanitari de Terrassa, Terrassa
• 12:45pm - 02:00pm PT

  Prostate-Specific Membrane Antigen (PSMA) Imaging Practice Patterns and Association with Androgen Deprivation Therapy Usage: Results from a Prospective Statewide Radiation Therapy Quality Consortium

  Speaker: Ryan Rebernick, PhD - University of Michigan, Ann Arbor
• 12:45pm - 02:00pm PT

  Prostate-Specific Membrane Antigen Targeted Imaging Utilization and its Association with Disease Progression and Treatment Changes in Patients with Metastatic Hormone-Sensitive Prostate Cancer and Metastatic Castration-Resistant Prostate Cancer

  Speaker: Jeetvan Patel, PhD - Novartis, East Hanover
• 12:45pm - 02:00pm PT

  PSA and PSMA Kinetics for Intermediate Risk, High- Very High Risk and Oligometastatic Prostate Cancer Patients Treated by Moderate Hypofractionated Radiotherapy (MHRT) and SBRT with Androgen Deprivation Therapy (ADT): A Single Center Prospective Database

  Speaker: Trinanjan Basu, MD - HCG Cancer Center, Mumbai
• 12:45pm - 02:00pm PT

  PSA Reduction as Predictor of Biochemical Relapse in Low and Favorable Intermediate Prostate Cancer Treated with Radical Radiotherapy

  Speaker: Andrea Allegra, MD - Department of Advanced Radiation Oncology, IRCSS "Sacro Cuore Don Calabria" Cancer Care Center, Negrar di Valpolicella (VR)
• 12:45pm - 02:00pm PT

  PSA Response to Neoadjuvant Androgen Deprivation Therapy (NA-ADT) and Long-Term Cancer Outcomes in Men Treated with Definitive External Beam Radiotherapy (EBRT) and High Dose Rate Brachytherapy Boost (HDRBT)

  Speaker: Marcus Cheng, MD, BBiomed - Alfred Health Radiation Oncology, Melbourne
• 12:45pm - 02:00pm PT

  PSMA Based Dose Escalation to Dominant Intraprostatic Lesion (DIL) in Localized Carcinoma Prostate Treated with Stereotactic Body Radiotherapy

  Speaker: Papaiah Susheela Sridhar, MD, DNB - Apollo Cancer centre,Bangalore, Bangalore
• 12:45pm - 02:00pm PT

  Quality Assurance in Head and Neck Radiation Therapy: A Prospective Analysis of Peer Review Recommendations in Disease-Site Specific Chart Rounds

  Speaker: Fara Dayani, MD, MS - Kaiser Permanente Los Angeles Medical Center, Los Angeles
• 12:45pm - 02:00pm PT

  Quantitative Magnetic Resonance Imaging to Differentiate Clinically Significant Tumor from Other Tissues in the Prostate

  Speaker: Jiahua Zhu, PhD - City of Hope National Medical Center, Duarte
• 12:45pm - 02:00pm PT

  Randomized PROSTATE-IQ Trial to Reduce ADT Treatment Burden for Patients with Biochemical Recurrence after Prostatectomy

  Speaker: Karen Hoffman, MD, FASTRO - The University of Texas MD Anderson Cancer Center, Houston
• 12:45pm - 02:00pm PT

  "Real World Experiences" -- from the Frontlines of a Community Practice Treating with Radiopharmaceuticals

  Speaker: Vivek Mehta, MD - Swedish Cancer Institute, Seattle
• 12:45pm - 02:00pm PT

  Real World Utilization of Salvage Radiotherapy (SRT) in Biochemically Recurrent (BCR) Prostate Cancer Patients

  Speaker: Mitchell Finkelstein, - Barrett, the Honors College Arizona State University, Tempe
• 12:45pm - 02:00pm PT

  Rectal-Avoidance PTV Margins in Prostate Radiation: A Large Volume Single-Institution Retrospective Series

  Speaker: Ramtin Rahmani, MD, BS - Providence Portland Medical Center, Portland
• 12:45pm - 02:00pm PT

  Re-Defining Risk Stratification in High-Risk Prostate Cancer: Integrating Biopsy Tumor Volume for Improved Prognostic Accuracy Beyond NCCN Criteria

  Speaker: Abed Rahman Kawakibi, MD - Department of Radiation and Cellular Oncology, University of Chicago, Chicago
• 12:45pm - 02:00pm PT

  Reduced Margin Daily AI-Assisted Online Adaptive Radiotherapy for Bladder Cancer

  Speaker: Philip Blumenfeld, MD, MPH - Hadassah Medical Center, Jerusalem
• 12:45pm - 02:00pm PT

  Reducing Radiotherapy Anxiety: Video-Guided Education on the Radiotherapy Process

  Speaker: Ya-Yun Yu, MD - China Medical University Hospital, Taichung
• 12:45pm - 02:00pm PT

  Risk Factor Analysis of Acute and Late Toxicity after Stereotactic Body Radiotherapy Using Prostate Cancer Patient Data from a Hydrogel Spacer Phase 2 Study

  Speaker: Mami Ogita, MD, PhD - The University of Tokyo Hospital, Bunkyo-ku
• 12:45pm - 02:00pm PT

  Safety and Early Outcomes of External Beam Radiation Therapy with Low Dose Brachytherapy Boost in Patients with Prostate Cancer

  Speaker: Zakaria El Kouzi, MD - MD Anderson Cancer Center, Houston
• 12:45pm - 02:00pm PT

  Safety and Efficacy of Postoperative Adjuvant Radiotherapy Combined with Immunotherapy in Patients with Upper Tract Urothelial Carcinoma

  Speaker: Xiaoying Li, MD - Peking University First Hospital, Beijng
• 12:45pm - 02:00pm PT

  Salvage Comprehensive Nodal VMAT with PSMA PET-Guided Boost plus ADT for Node-Only Relapse after Definitive Prostate IMRT

  Speaker: Haripriya Vettivelu, BMed - Mid North Coast Cancer Institute (MNCCI) Coffs Harbour, Coffs Harbour
• 12:45pm - 02:00pm PT

  Salvage Re-Irradiation for Prostate Cancer: A Contemporary Prospective Experience

  Speaker: Samuel Lichtman-Mikol, MD - Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland
• 12:45pm - 02:00pm PT

  Salvage Stereotactic Radiotherapy Post-Nephrectomy for Recurrent Renal Cell Carcinoma

  Speaker: Tidie Song, BS - UT Southwestern Medical Center, Dallas
• 12:45pm - 02:00pm PT

  Separation Effect of Biodegradable Balloon Spacer on Rectal Dose from Apex to Base in Prostate Cancer SBRT

  Speaker: Edward Soffen, MD - Princeton Radiation Oncology, Monroe
• 12:45pm - 02:00pm PT

  Single-Cell and Bulk Transcriptomes Reveal a Two-Gene Based Clinically Subtypes for Gleason Grade 5 Prostate Cancer Patients Receiving Radiotherapy

  Speaker: Fuhao Wang, MD - Peking University First Hospital, Beijing
• 12:45pm - 02:00pm PT

  Single-Dose Radiotherapy (SDRT) with Dominant Intraprostatic Lesion Simultaneous Integrated Boost (SIB-DIL) in Unfavorable Intermediate Risk Prostate Cancer: Preliminary Results from a Phase II Trial

  Speaker: Carlo Greco, MD - CCU, Lisbon
• 12:45pm - 02:00pm PT

  Social Determinants of Health in Radiation Oncology Patient Safety Incidents

  Speaker: Javier Mora, MD - Harvard Radiation Oncology Program, Boston
• 12:45pm - 02:00pm PT

  Sparing the Urethra, Pudendal Arteries and Rectum during Stereotactic Ablative Body Radiotherapy (RT) for Prostate Cancer (SUPR-SABR): Acute Toxicity and Dosimetric Analysis of an Ongoing Trial

  Speaker: Harriet Eldredge-Hindy, MD - Medical University of South Carolina, Charleston
• 12:45pm - 02:00pm PT

  Spatial and Dosimetric Analysis of Local Recurrence Patterns after Trimodality Therapy for Bladder Cancer

  Speaker: Matthew Whitmill, MD - UNC Health, Chapel Hill
• 12:45pm - 02:00pm PT

  STARLiT: A Single Arm Phase I/II Trial of STereotActic Body Radiotherapy and ¹⁷⁷Lutetium PSMA in Locally Advanced Prostate Cancer

  Speaker: Qing Li, MD, PhD - UH Cleveland Medical Center, Cleveland
• 12:45pm - 02:00pm PT

  Stereotactic Body Radiation Therapy to Only Prostate and Proximal Seminal Vesicles is a Viable Option for a Favorable Subset of High-Risk Prostate Cancer Patients

  Speaker: Nima Aghdam, MD, MS - NYU Langone Health, New York
• 12:45pm - 02:00pm PT

  Study of Daily Criteria-Based Online Adaptive Radiotherapy with Radiomics and Dosimetry for Postoperative Prostate Cancer

  Speaker: Guanghui Gan, - The First Affiliated Hospital of Soochow University, Soochow
• 12:45pm - 02:00pm PT

  Synthetic CT Generation for Ultrasound-Based Prostate HDR Brachytherapy Using a Cycle Diffusion Model

  Speaker: Ruirui Liu, PhD - University of Nebraska Medical Center, Omaha
• 12:45pm - 02:00pm PT

  Telemedicine Experiences among Radiation Oncologists: A Pilot Study at an Integrated Health Care System in California

  Speaker: Haocheng Cai, DO, PhD - Kaiser Permanente Los Angeles Medical Center, Los Angeles
• 12:45pm - 02:00pm PT

  Testosterone Recovery after Cessation of Luteinizing Hormone-Releasing Hormone Antagonists in Treatment of Prostate Cancer

  Speaker: Nathan Lin, - City of Hope, Glendale
• 12:45pm - 02:00pm PT

  The Impact of ARBs and ACE Inhibitors during Chemoradiotherapy on Outcomes for Muscle Invasive Bladder Cancer

  Speaker: Yasmine Baker, - University of California, San Francisco, San Francisco
• 12:45pm - 02:00pm PT

  The Impact of Femoral Head Radiation Doses on Hip Pain in Intensity Modulated Proton Therapy for Prostate Cancer: A Retrospective Analysis

  Speaker: Charles Shang, MB, MS - South Florida Proton Therapy Institute, Delray Beach
• 12:45pm - 02:00pm PT

  The Impact of Neck Tilt on Deep Learning Autosegmentation Accuracy for Head and Neck Radiotherapy

  Speaker: Jamison Brooks, PhD - Mayo Clinic Rochester, Rochester
• 12:45pm - 02:00pm PT

  The Impact of Stepwise Nutritional Intervention Combined with Individualized Nutritional Management on the Nutritional Status of Patients with Head and Neck Tumors Undergoing Radiotherapy: A Randomized Controlled Trial

  Speaker: Juanli Shi, - Xijing Hospital Air Force Medical University, Xi’an
• 12:45pm - 02:00pm PT

  The Performance of PET and Multiparametric MRI in Identification of Intraprostatic Tumor Deposits after Prostate Radiation Therapy

  Speaker: Ting Martin Ma, MD, PhD - University of Washington, Seattle
• 12:45pm - 02:00pm PT

  The Potential Impact of Immunotherapy on Hypofractionated Trimodality Therapy in Bladder Cancer

  Speaker: Sravya Koduri, MD, BS - NYU Langone Health, New York
• 12:45pm - 02:00pm PT

  Timing of Molecular PET Imaging after Salvage Radiation Therapy for Recurrent Oligometastatic Castration-Sensitive Prostate Cancer

  Speaker: Jarey Wang, MD, PhD - Johns Hopkins University School of Medicine, Baltimore
• 12:45pm - 02:00pm PT

  To Space or Not to Space: The EPIC question for Prostate Stereotactic Radiation (SBRT) with or without Hydrogel Rectal Spacer (RS)

  Speaker: Madeline Flanagan, MD - Baylor College of Medicine, Houston
• 12:45pm - 02:00pm PT

  Toxicity Assessment of Combined External Beam Radiation with [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy

  Speaker: Ross Weber, MD, PhD - Memorial Sloan Kettering Cancer Center, New York
• 12:45pm - 02:00pm PT

  Toxicity Outcomes in Bladder Cancer Treated with Tri-Modality Therapy Using Hypofractionated Bladder Only Radiation with or without Immunotherapy

  Speaker: Andrew Wanna, MD - New York University Cancer Center, New York
• 12:45pm - 02:00pm PT

  Treatment Choices and Toxicity Outcomes in Patients with a High Risk PROSTOX Score

  Speaker: Joanne Weidhaas, MD, PhD - UCLA Radiation Oncology, Los Angeles
• 12:45pm - 02:00pm PT

  Treatment Outcomes of Radiation Therapy with Androgen Deprivation Therapy in Patients with N1 Prostate Cancer

  Speaker: Kayeong Shin, MD - MD Anderson Cancer Center, Houston
• 12:45pm - 02:00pm PT

  Trends in Cost Differences between Active Surveillance and Radiation Therapy for Low- and Favorable Intermediate-Risk Prostate Cancer

  Speaker: Jiaye Shen, PhD - University of Kansas Medical Center, Kansas City
• 12:45pm - 02:00pm PT

  Trial in Progress: A Phase II Single-Arm Study Testing SBRT, Adenosine Signaling Modulation, and Immune Checkpoint Inhibition for Men with Hormone Sensitive Oligometastatic Prostate Cancer (SBRT-AMICO)

  Speaker: Madhav Patel, MD, BS - Columbia Presbyterian Medical Center, New York
• 12:45pm - 02:00pm PT

  Trial in Progress: Randomized Phase II Trial of Targeted Radiation with No Castration for Treatment of Metastatic Castration-Resistant Prostate Cancer

  Speaker: Sasha Ebrahimi, MD, PhD - UCLA Radiation Oncology, Los Angeles
• 12:45pm - 02:00pm PT

  Tri-Modality Treatment with or without Pembrolizumab for Selected Patients with Muscle-Invasive Bladder Cancer

  Speaker: Shang-Bin Qin, MD - Peking University First Hospital, Beijing
• 12:45pm - 02:00pm PT

  TWO- vs. Five-fraction Magnetic Resonance-Guided Adaptive Radiotherapy with DOminant-TArgeted Boost in Localized Prostate Cancer (DOTA-2) by MR-Linac: Interim Analysis of Circulating Lymphocyte Change in a Phase II Randomized Trial

  Speaker: Ratchapas Romrattaphan, MD - Siriraj Hospital Mahidol University, Bangkok
• 12:45pm - 02:00pm PT

  Urethra Sparing in Robotic SBRT for Localized Prostate Cancer with Simultaneous Focal Boost to MR-Defined High PI-RADS Score Intra-Prostatic Lesions: A Dosimetric Analysis

  Speaker: Hong Xiang, PhD, DABR - Penn Medicine Lancaster General Health, Lancaster
• 12:45pm - 02:00pm PT

  Urethral Dose as a Predictor of Genitourinary Toxicity and Patient-Reported Quality of Life after Prostate Stereotactic Body Radiotherapy with Focal Intraprostatic Boost: Secondary Analysis of a Phase 2 Trial

  Speaker: Mustafa Basree, DO, MS - University of Wisconsin Hospitals and Clinics, Madison
• 12:45pm - 02:00pm PT

  Urethra-Sparing Prostate Cancer Radiotherapy: Current Practices and Future Insights from an International Survey

  Speaker: Jennifer Le Guevelou, MD - Laboratoire du traitement de l'image et du signal, université de Rennes, Rennes
• 12:45pm - 02:00pm PT

  Urinary Organs at Risk for Prostate Cancer External Beam Radiation Therapy: Contouring Guidelines

  Speaker: Jennifer Le Guevelou, MD - Laboratoire du traitement de l'image et du signal, université de Rennes, Rennes
• 12:45pm - 02:00pm PT

  Urinary Toxicity after External Beam Radiation Therapy for Prostate Cancer following Transurethral Resection of Prostate or Laser Enucleation

  Speaker: Pranalee Patel, MD - MD Anderson Cancer Center, Houston
• 12:45pm - 02:00pm PT

  Using Deep Learning to Delineate the Elective Pelvic Nodal Volumes in Patients with Prostate Cancer: A Tool Aimed to Facilitate Peer Review

  Speaker: Brian Anderson, PhD - UC San Diego Radiation Medicine and Applied Sciences, La Jolla
• 12:45pm - 02:00pm PT

  Utilization of a 46 Gene Assay Genomic Test with Clinicopathologic Factors in Unfavorable Intermediate to Very High Risk Prostate Cancer To Predict Upstaging Via PSMA PET/CT Scan

  Speaker: Robert Kwon, MD - VA Long Beach Healthcare, LONG BEACH